Open access · CC-BY
via OpenAlex
Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
Marie Y. Davis, Kien Trinh, Ruth E. Thomas, Selina Yu, Alexandre A. Germanos, Brittany N. Whitley, S. Pablo Sardi, Thomas Jude Montine, Leo J. Pallanck
PLoS Genetics · 2016 · ▲ 308 citations
Abstract
Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher's disease, and are the most common genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB) excluding variants of low penetrance. Because α-synuclein-containing neuronal aggregates are a defining feature of PD and DLB, it is widely believed that mutations in GBA1 act by enhancing α-synuclein toxicity. To explore this hypothesis, we deleted the Drosophila GBA1 homolog, dGBA1b, and compared the phenotypes of dGBA1b mutants in the presence and absence of α-synuclein expression. Homozygous dGBA1b mutants exhibit shortened lifespan, locomotor and memory deficits, neurodegeneration, and dramatically increased accumulation of ubiquitinated protein aggregates that are normally degraded through an autophagic mechanism. Ectopic expression of human α-synuclein in dGBA1b mutants resulted in a mild enhancement of dopaminergic neuron loss and increased α-synuclein aggregation relative to controls. However, α-synuclein expression did not substantially enhance other dGBA1b mutant phenotypes. Our findings indicate that dGBA1b plays an important role in the metabolism of protein aggregates, but that the deleterious consequences of mutations in dGBA1b are largely independent of α-synuclein. Future work with dGBA1b mutants should reveal the mechanism by which mutations in dGBA1b lead to accumulation of protein aggregates, and the potential influence of this protein aggregation on neuronal integrity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pgen.1005944
- Canonical
- link ↗
- Fetched
- 2026-09-22 MST
Cite this
APA
Davis, M.Y., Trinh, K., Thomas, R.E., Yu, S., Germanos, A.A., Whitley, B.N., Sardi, S.P., Montine, T.J., & Pallanck, L.J. (2016). Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration. <em>PLoS Genetics</em>. https://doi.org/10.1371/journal.pgen.1005944
Vancouver
Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, et al. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration. PLoS Genetics. 2016. doi:10.1371/journal.pgen.1005944.
BibTeX
@article{marie2016Glucoc,
title = {Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration},
author = {Marie Y. Davis and Kien Trinh and Ruth E. Thomas and Selina Yu and Alexandre A. Germanos and Brittany N. Whitley and S. Pablo Sardi and Thomas Jude Montine and Leo J. Pallanck},
journal = {PLoS Genetics},
year = {2016},
doi = {10.1371/journal.pgen.1005944},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain 2016
Open access · OA
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease
Purdue e-Pubs (Purdue University System) 2010
Preprint
Role of alpha-synuclein primary structure and oxidative stress in Parkinson's disease pathology
Movement Disorders 2006
Open access · OA
Levels of alpha‐synuclein mRNA in sporadic Parkinson disease patients
Movement Disorders 2020
Open access · CC-BY
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Journal of Neurochemistry 2016
Open access · CC-BY
The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
Current Neuropharmacology 2018
Open access · OA